Quattro Financial Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Quattro Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$0.28 - $1.16 $7,000 - $28,999	25,000 Added 14.29%	200,000 $66,000
Q1 2024 Apr 18, 2024	BUY	$1.06 - $1.67 $185,497 - $292,246	174,998 Added 8749900.0%	175,000 $203,000
Q4 2023 Jan 30, 2024	SELL	$1.26 - $1.79 $220,497 - $313,246	-174,998 Reduced 100.0%	2 $0
Q3 2023 Oct 20, 2023	BUY	$1.61 - $2.54 $120,750 - $190,500	75,000 Added 75.0%	175,000 $316,000
Q2 2023 Jul 25, 2023	BUY	$1.14 - $1.95 $113,999 - $195,000	100,000 New	100,000 $186,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Quattro Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Quattro Financial Advisors LLC with notifications on news.